Recent studies have suggested that VILIP-1 could serve as a promising biomarker for AD diagnosis and prognosis, as its levels are significantly elevated in patients with AD compared to healthy controls, correlating with cognitive decline and brain atrophy [86]. The gene discussed is VSNL1; the disease is Alzheimer disease.